Plain-English translation of NCT06858553 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing a new artificial intelligence tool designed to help doctors detect intestinal scarring (called fibrosis) in patients with Crohn's disease. Researchers will use MRI scans and computer analysis to teach an AI system to recognize scarring patterns, then test whether this tool works reliably for other patients. The goal is to eventually help doctors diagnose and monitor this serious complication more accurately.
Intestinal scarring is a common and serious problem in Crohn's disease that can narrow the bowel and cause blockages, sometimes requiring surgery. Currently, doctors rely on imaging and clinical judgment to detect scarring, but these methods aren't always consistent or reliable. This study aims to develop a computer-based tool that could help doctors spot scarring earlier and more accurately, potentially improving patient outcomes.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would have an MRI scan of your abdomen before undergoing your scheduled bowel surgery. The study team will collect and analyze images from your MRI scan and tissue samples from the part of your bowel that is surgically removed. Your information will be used to train and test the new AI tool—some participants help train the system, while others help verify it works correctly.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China